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Background: This study presents descriptive epidemiological data related to breast cancer cases 
diagnosed from 2001 to 2008 among Saudi women, including the frequency and percentage of 
cases, the crude incidence rate (CIR), and the age-standardized incidence rate (ASIR), adjusted 
by the region and year of diagnosis.
Methods: This is a retrospective descriptive epidemiological study of all Saudi female breast 
cancer cases from 2001 to 2008. The statistical analyses were conducted using descriptive 
statistics, a linear regression model, and analysis of variance with the Statistical Package for 
the Social Sciences version 20.0.
Results: A total of 6,922 female breast cancer cases were recorded in the Saudi Cancer Reg-
istry from 2001 to 2008. The highest overall percentages (38.6% and 31.2%) of female breast 
cancer cases were documented in women who were 30–44 and 45–59 years of age, respectively. 
The eastern region of Saudi Arabia had the highest overall ASIR, at 26.6 per 100,000 women, 
followed by Riyadh at 20.5 and Makkah at 19.4. Jazan, Baha, and Asir had the lowest average 
ASIRs, at 4.8, 6.1, and 7.3 per 100,000 women, respectively. The region of Jouf (24.2%; CIR 
11.2, ASIR 17.2) had the highest changes in CIR and ASIR from 2001 to 2008. While Qassim, 
Jazan, and Tabuk recorded down-trending rates with negative values.
Conclusion: There was a significant increase in the CIRs and ASIRs for female breast cancer 
between 2001 and 2008. The majority of breast cancer cases occurred among younger women. 
The region of Jouf had the greatest significant differences of CIR and ASIR during 2001 to 2008. 
Jazan, Baha, and Najran had the lowest average CIRs and ASIRs of female breast cancer, whereas 
the linear trend upward is a concern in certain regions, such as the eastern region, Makkah, and 
Riyadh. However, further analytical epidemiological research is needed to identify the potential 
risk factors involved in the increase in the prevalence of breast cancer among Saudi women.
Keywords: epidemiology, breast cancer, morbidity measure, public health, cancer 
epidemiology
Introduction
Breast cancer is not only a significant problem in Saudi Arabia but is also considered to 
be one of the most common causes of cancer-related mortality worldwide. Thousands 
of women throughout the world have been clinically diagnosed with breast cancer.1–4 
In addition, breast cancer has become a significant problem in both developed and 
developing countries.5–8 It is estimated that more than one million new cases of breast 
cancer are diagnosed annually.9
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In Saudi Arabia, the International Agency for Research 
on Cancer estimated that the age-standardized incidence rate 
(ASIR) for breast cancer was 22.4 per 100,000 women in 
2008, and the age-standardized mortality rate was 10.4 per 
100,000 women.10 Furthermore, in 2011, the registry of King 
Faisal Specialist Hospital and Research Centre reported that 
the number of breast cancer cases has increased considerably, 
especially among the younger age group.6 Despite the lower 
crude incidence rate (CIR) of female breast cancer in Saudi 
Arabia compared with other developed countries, the Saudi 
Cancer Registry (SCR) reported that cancer of the female 
breast was the most common cancer among Saudi woman 
during a 14-year period (1994–2008).
This is the first epidemiological observational descrip-
tive study of female breast cancer in Saudi Arabia. Despite 
insufficient information regarding female breast cancer in 
Saudi Arabia, with the exception of the SCR reports, we 
attempt to study the real situation of female breast cancer 
in different regions of Saudi Arabia during 2001 to 2008. 
Therefore, we perform the first step in epidemiologic study 
of disease, including time, place, and characteristics of 
persons.11 The main aims of this study were to describe 
the burden of breast cancer among Saudi women during an 
8-year period (2001–2008). In addition, this study provides 
a summary of the regional patterns and trends, related to 
the CIR and the ASIR, of breast cancer cases among Saudi 
women.
Materials and methods
We conducted a retrospective descriptive epidemiological 
study of all Saudi female breast cancer cases diagnosed 
between January 2001 and December 2008. The data regard-
ing cancer in Saudi Arabia are publicly available and easily 
accessible. This study was made possible by the SCR, which 
is a population-based registry established in 1994 through 
the Ministry of Health in Saudi Arabia. The latest report of 
the SCR was published in 2008, and no additional reports 
were published until 2013.
Since 2001, the SCR has provided reports on the pattern 
of cancer in Saudi Arabia, with a primary objective of defin-
ing the population-based incidence of the disease. On the 
basis of these data, there are currently comprehensive reports 
for 13 administrative regions from 2001 to 2008 that discuss 
the frequency with the percentage of cases, the CIR, and the 
ASIR, adjusted by the provinces of Saudi Arabia and years 
of diagnosis. This study was conducted using these reports 
to critically gather all of the information from the SCR with 
the aim of presenting the descriptive epidemiology of female 
breast cancer in Saudi Arabia.
For data analysis, we used the Statistical Package for the 
Social Sciences version 20.0 (IBM Corporation, Armonk, 
NY, USA). The descriptive analysis of the epidemiological 
data was performed by calculating the overall percentage, the 
CIR, and the ASIR adjusted by the age group, region, and 
year of diagnosis. The percentage was calculated by adding 
the number of cases of female breast cancer and then divid-
ing that number by the total number of female cancer cases. 
Furthermore, an analysis of variance test was performed to 
determine any significant differences among the regions and 
years of diagnosis.12 In addition, the linear regression model 
that investigates the strength of the association between inde-
pendent variables and an outcome was applied to predict the 
annual the annual CIR and ASIR for breast cancer among 
Saudi women.13
The overall age-standardized rates per 100,000 women 
were calculated for all of the SCR reports based on a (Segi) 
standard for World populations who have an intermediate-
age. This is a particularly important rate when making 
comparisons between different populations with respect to 
the age structure.14,15
Results
A total of 6,922 female breast cancer cases were diagnosed 
and recorded in the SCR between January 2001 and Decem-
ber 2008. The number of women with breast cancer increased 
steadily from 2001 to 2006. On the basis of the number of 
cases of breast cancer and their percentages, the rate appears 
to be increasing. For example, in Figure 1A and B, it can 
been seen that there were 545 cases in 2001 (19.9%; 95% 
confidence interval [CI], 15.1%–24.7%). This figure rose to 
614 by 2002, representing an increase of 1.2%. By 2007, 
there were 1,239 cases reported, corresponding to a 6.1% 
increase; this was the highest figure reported by the SCR. 
Interestingly, the figure dropped to 1,152 cases in 2008, 
representing a decline of 1%.
The distribution of female breast cancer cases by age 
groups from 2001 to 2008 was calculated from the SCR. The 
overall number of cases and percentages shows the age groups 
most and least affected by breast cancer in Saudi Arabia dur-
ing the 2001 to 2008 (Table 1; Figure 1C and D). The groups 
reported correspond to ages 15–29, 30–44, 45–59, 60–74, 
and older than 75 years. According to the overall numbers and 
percentages, the age groups that were least affected by breast 
cancer were women older than 75 years, at 10.2%, followed by 
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those within the range of 15–29 years, at 10%. Alternatively, 
the group of younger Saudi women, those aged 30–44 years, 
recorded the highest overall number and percentage, with 327 
cases representing 38.6% of the total number of female breast 
cancer cases, followed by women aged 45–59 years, with 323 
cases representing 31.2%. These figures suggest that most of 
the female breast cancer cases in developing countries occur 
in women younger than 50 years.5–8
The CIRs of female breast cancer adjusted by year of 
diagnosis from 2001 to 2008 indicate a steady increase 
between 2001 and 2006. According to Table 2 and Figure 2A, 
a CIR of 6.8 per 100,000 women (95% CI, 4.61–8.99 per 
100,000 women) was estimated in 2001, and a CIR of 11.4 
per 100,000 women (95% CI, 7.9–15.7 per 100,000 women) 
was estimated in 2006. In 2007, the CIR of 14.3 per 100,000 
women (95% CI, 11.1–17.5 per 100,000 women) was signifi-
cantly higher compared with the other years [F(7, 96) =3.066; 
P,0.001]. However, this figure dropped by 1.4 points in 
2008. On the basis of the linear regression trend, this result 
was statistically significant [F(1, 102) =23.328; P,0.001]. 
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Figure 1 (A and B) number and percentage of female breast cancer cases in saudi arabia from 2001 to 2008. (C and D) Overall number and percentage of female breast 
cancer cases distribution by age group in saudi arabia from 2001 to 2008.
Table 1 Female breast cancer distribution by age group in saudi arabia from 2001 to 2008
Year Age group
0–14 15–29 30–44 45–59 60–74 $75 Total
n % n % n % n % n % n % n %
2001 0 0 22 7.1 222 36.2 181 27.2 91 13.7 29 10.2 545 19.9
2002 0 0 26 8 246 38.9 216 28.3 95 14.1 31 10 614 21.1
2003 0 0 33 9.5 246 33.8 257 29.2 117 14.7 23 8.5 676 20.8
2004 0 0 38 10.5 305 38.1 290 31.7 116 13.5 34 11.7 783 22.4
2005 0 0 36 9 367 41.4 341 32.5 150 16.8 38 10.4 932 24.3
2006 0 0 45 11.5 364 38.4 374 33.3 159 15.3 39 9.7 981 23.6
2007 0 0 58 11.6 449 41.6 471 33.9 220 20 41 9.1 1,239 26
2008 0 0 56 12.5 415 40.2 453 33.5 176 16.3 52 11.8 1,152 25
average 0 0 39.3 10 326 38.6 405 31.2 141 15.6 36 10.2 865 22.9
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Therefore, the equation for a straight line to predict the 
annual CIR of female breast cancer in Saudi Arabia is 
4.28 + (0.76 × years), and the incidence of breast cancer 
increased by a predicted average of 0.76 per 100,000 Saudi 
women per year. The correlation coefficient (R) for the CIR is 
0.65, which indicates a moderate correlation. The coefficient 
of determination R2=0.42, which means that the explanatory 
variable (years) explains 42% of the variability of the depen-
dent variable (CIR).
The overall CIR of female breast cancer, adjusted by 
region from 2001 to 2008, per 100,000 women was estimated 
from the SCR, as shown in Table 3 and Figure 2B. The eastern 
region of Saudi Arabia had the highest overall CIR for female 
breast cancer, at 15.4 per 100,000 women (95% CI, 12.8–17.9 
Table 2 Confidence interval for percentage, crude incidence rate, and age-standardized incidence rate of female breast cancer cases 
in saudi arabia from 2001 to 2008
Year Percentage Crude incidence rate  
per 100,000
Age-standardized incidence rate  
per 100,000
% 95% CI,  
lower
95% CI,  
upper
Crude incidence 
rate
95% CI,  
lower
95% CI,  
upper
Age-standardized 
incidence rate
95% CI,  
lower
95% CI, 
upper
2001 19.9 15.1 24.7 6.8 4.61 8.99 11.8 7.9 15.7
2002 21.1 17.8 24.4 7.9 6.3 9.5 12.6 9.2 16
2003 20.8 16.9 24.7 8.4 6.3 10.5 13.9 9.9 17.9
2004 22.4 18.4 26.4 9.5 7.3 11.7 15.4 11.8 19
2005 24.3 18.7 29.9 11 7.9 14.1 18 12.7 23.3
2006 23.6 19.6 27.6 11.4 8.6 14.2 18.1 13.9 22.3
2007 26 22.6 29.4 14.3 11.1 17.5 21.6 16.8 26.4
2008 25 21.2 28.8 12.9 10.2 15.6 19.2 14.8 23.6
Overall 22.9 18.8 27.0 10.3 7.8 12.8 16.3 12.1 20.5
Abbreviation: CI, confidence interval.
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Figure 2 (A) Crude incidence rate (Cir) of female breast cancer cases in saudi arabia from 2001 to 2008. (B) Overall crude incidence rate of female breast cancer cases 
in the regions of saudi arabia from 2001 to 2008. (C) Age-standardized incidence rate (ASIR) of female breast cancer cases in Saudi Arabia from 2001 to 2008. (D) Overall 
age-standardized incidence rate of female breast cancer cases in the regions of Saudi Arabia from 2001 to 2008.
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per 100,000 women), followed by Makkah, at 12.7 per 
100,000 women (95% CI, 9.4–16.1 per 100,000 women), and 
Riyadh, at 12.0 per 100,000 women (95% CI, 9.7–14.2 per 
100,000 women). These findings are consistent with those 
reported by Ibrahim et al, demonstrating that, on average, the 
eastern regions of Saudi Arabia had the highest numbers of 
cases of breast cancer between 1999 and 2003.16 However, 
the analysis of variance test revealed that the incidence of 
breast cancer was significantly higher for these regions com-
pared with other parts of Saudi Arabia [F(12, 91) =13.852; 
P,0.001]. Furthermore, Jazan (95% CI, 1.9–4.4 per 100,000 
women), Baha (95% CI, 2.0–6.8 per 100,000 women), and 
Najran (95% CI, 2.5–6.5 per 100,000 women) had the lowest 
average CIRs for breast cancer among Saudi women at 3.1, 
4.4, and 4.5 per 100,000 women, respectively.
The world ASIR of female breast cancer per 100,000 
women, adjusted for the region and the year of diagnosis, 
suggests a similar trend to that seen for the CIR from 2001 
to 2008 (Figure 2C and D). There was an increase in the 
number of cases of female breast cancer diagnosed between 
2001 and 2008, with the highest ASIR of 21.6 per 100,000 
women reported in 2007 (95% CI, 16.8–26.4 per 100,000 
women), followed by a slight decrease in the ASIR to 
19.2 per 100,000 women in 2008 (95% CI, 14.8–23.6 per 
100,000 women), according to reports released by the SCR. 
In addition, the results of the linear regression model were 
also statistically significant [F (1,102) =10.341; P,0.001]. 
Therefore, the equation for the straight line to predict 
the annual ASIR of female breast cancer in Saudi Arabia 
is 8.80 + (0.90 × years). The (R) for the ASIR is 0.55, 
which indicates a moderate correlation. The coefficient of 
determination R2=0.30, which means that the explanatory 
variable (years) explains 30% of the variability of the depen-
dent variable (ASIR).
Similarly, the eastern part of Saudi Arabia had the highest 
mean ASIR, at 26.6 per 100,000 women (95% CI, 23.2–30.0 
per 100,000 women), followed by Riyadh at 20.5 per 100,000 
women (95% CI, 17.7–23.3 per 100,000 women) and Makkah 
at 19.4 per 100,000 women (95% CI, 15.4–23.4 per 100,000 
women), and the analysis of variance was statistically sig-
nificant for these regions compared with other provinces of 
Saudi Arabia [F (12, 91) =21.966; P,0.001]. Jazan (95% 
CI, 2.8–6.8 per 100,000 women) and Baha (95% CI, 2.7–9.5 
per 100,000 women) had the lowest mean ASIRs, at 4.8 and 
6.1 per 100,000 women, respectively.
The differences in the CIR and ASIR between 2001 and 
2008 were calculated from the data in the SCR to investigate 
the burden of female breast cancer among Saudi women in 
different regions (Table 4). The greatest changes in percent-
ages were observed in the regions of Jouf (24.2%; 11.2 CIR, 
17.2 ASIR), Hail (12.5%; 6 CIR, 7.3 ASIR), Baha (11.6%; 5.9 
CIR, 9.3 ASIR), and Najran (9%; 4.2 CIR, 5 ASIR). However, 
the CIR and ASIR for these regions, with the exception of 
Jouf, are still lower than the annual predicted values based 
on the equations for the linear regression: 4.28 + (0.76 × 8 
years =10.4) per 100,000 women for the CIR and 8.8 + (0.9 × 
8 years =16) per 100,000 women for the ASIR. The smallest 
changes in the CIR and ASIR were detected in the regions 
of Qassim (−10.7%; −1.5 CIR, 1.4 ASIR), Jazan (−1.7%; 
1.1 CIR, 2.2 ASIR), and Tabuk (2%; 2.4 CIR, 4.8 ASIR). 
Therefore, these regions recorded down-trending rates with 
negative values from 2001 to 2008. The likely explanation 
Table 3 Confidence interval for overall percentage, crude incidence rate, and age-standardized incidence rate of female breast cancer 
cases in the regions of saudi arabia from 2001 to 2008
Regions Overall percentage Overall crude incidence rate Overall age-standardized incidence rate
% 95% CI,  
lower
95% CI,  
upper
Crude incidence  
rate
95% CI,  
lower
95% CI,  
upper
Age-standardized  
incidence rate
95% CI,  
lower
95% CI, 
upper
asir 13.5 11.7 15.2 4.7 3.6 5.8 7.3 6.0 8.7
Baha 14.7 10.2 19.1 4.4 2.0 6.8 6.1 2.7 9.5
Jazan 14.1 9.0 19.1 3.1 1.9 4.4 4.8 2.8 6.8
Madinah 19.3 16.4 22.2 7.2 4.8 9.5 11.8 9.2 14.3
hail 20.0 14.3 25.6 6.5 3.8 9.2 9.3 6.0 12.7
Qassim 25.2 21.8 28.5 8.8 7.1 10.5 13.4 11.7 15.1
riyadh 21.5 19.4 23.7 12.0 9.7 14.2 20.5 17.7 23.3
Makkah 26.1 23.9 28.3 12.7 9.4 16.1 19.4 15.4 23.4
najran 14.9 9.6 20.2 4.5 2.5 6.5 8.1 4.5 11.7
Jouf 22.0 15.8 28.2 7.4 4.4 10.4 12.4 7.5 17.2
Tabuk 19.7 16.6 22.9 7.4 5.2 9.6 15.1 12.1 18.2
eastern region 29.0 26.8 31.1 15.4 12.8 17.9 26.6 23.2 30.0
northern region 13.5 6.4 20.7 4.8 2.6 6.9 9.4 5.2 13.5
Abbreviation: CI, confidence interval.
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for the down-trending rates with negative values in certain 
regions include insufficient screening programs and that a 
smaller number of women are undergoing diagnostic tests 
for breast cancer.
Discussion
The descriptive epidemiology of breast cancer in Saudi 
Arabia provides an important explanation for the recent trend, 
confirming the significance of the disease among women. 
The results of our study are based on the data recorded in the 
SCR, showing that female breast cancer is one of the most 
significant causes of disease among women.17,18 The findings 
of our study indicate that the eastern region, Makkah, and 
Riyadh have the highest overall CIRs and ASIRs for female 
breast cancer in Saudi Arabia, whereas the CIRs and ASIRs 
in these regions did not increase above the expected levels 
during 2001 to 2008. Alternatively, the regions of Jazan, 
Baha, and Najran had the lowest values in the average CIR 
and ASIR. The age group most affected by breast cancer in 
Saudi Arabia and in other developing countries is women 
younger than 50 years of age.5–8 However, developed coun-
tries have higher breast cancer incidence rates among women 
aged 50 years and older.19
In this study, we have reported the changes in the percent-
age, CIR, and ASIR from 2001 to 2008. Jouf had the highest 
differences in rates, which were above the predicted values 
for the CIR and ASIR during 2001 to 2008. These differences 
suggest that the region of Jouf has been affected more by 
female breast cancer during an 8-year period (2001–2008). 
In addition, the rates of female breast cancer decreased in 
the regions of Qassim, Jazan, and Tabuk. These regions had 
the lowest changes, with down-trending in the CIR and ASIR 
of the disease from 2001 to 2008.
In our descriptive epidemiological study, we suggest 
conducting screening programs for the early detection and 
treatment of breast cancer in Saudi women. The target areas 
for breast cancer screening programs are the regions with 
highest CIRs and ASIRs. In addition, we try to explore 
the distribution of female breast cancer cases among Saudi 
women and provide very important information for health 
researchers. Therefore, further hypothesis tests may be gen-
erated to study the potential risk factors of breast cancer in 
different regions of Saudi Arabia. The most common types 
of analytical observational epidemiological studies are 
case–control and cohort studies. Both studies can be used to 
determine the association between the risk factors and breast 
cancer.13 In addition, these epidemiological studies will assist 
in the prevention of breast cancer through identifying the 
major risk factors that attribute to the increase of the CIR 
and ASIR. In addition, the availability of cancer reports from 
SCR may encourage researchers to conduct more descriptive 
epidemiological studies for other types of cancer among the 
Saudi population.
Conclusion
It is clear from the epidemiological analysis of the reports 
registered by the SCR from 2001 to 2008 that the CIRs 
and ASIRs of female breast cancer are increasing annu-
ally. Jazan, Baha, and Najran had the lowest average CIRs 
and ASIRs of female breast cancer, whereas the linear 
trend upward is a concern in certain regions, such as the 
eastern region, Makkah, and Riyadh. As discussed earlier, 
Table 4 Differences in the percentage, crude incidence rate, and age-standardized incidence rate of female breast cancer cases in the 
regions of saudi arabia between 2001 and 2008
Regions Percentage Crude incidence rate  
per 100,000
Age-standardized incidence rate 
per 100,000
2008 2001 Difference 2008 2001 Difference 2008 2001 Difference
asir 15.5 11 4.5 6.4 2.8 3.6 9 4.8 4.2
Baha 19.1 7.5 11.6 7.2 1.3 5.9 10.8 1.5 9.3
Jazan 14.1 15.8 −1.7 3.8 2.7 1.1 6 4.2 2.2
Madinah 20.4 15.9 4.5 9.1 4.1 5 12.2 7.8 4.4
hail 24.4 11.9 12.5 8.9 2.9 6 11.9 4.6 7.3
Qassim 21.7 32.4 −10.7 7.8 9.3 −1.5 13.3 11.9 1.4
riyadh 23.9 18.6 5.3 15 9.5 5.5 24.2 17.5 6.7
Makkah 27.4 23 4.4 15.4 7.4 8 21.6 13 8.6
najran 20.9 11.4 9.5 7.2 3 4.2 10.8 5.8 5
Jouf 33.3 9.1 24.2 12.5 1.3 11.2 19.4 2.2 17.2
Tabuk 22 20 2 8.8 6.4 2.4 17.2 12.4 4.8
eastern region 32.4 26 6.4 19.7 12 7.7 31.8 22 9.8
northern region 13 4 9 5.4 4.2 1.2 10.5 8.3 2.2
Abbreviation: CI, confidence interval.
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the region of Jouf recorded the greatest significant differ-
ences of the CIRs and ASIRs between 2001 and 2008, with 
Qassim, Jazan, and Tabuk having the lowest. The majority 
of women with breast cancer are in a younger age group. 
However, further analytical epidemiological research is 
needed to identify the potential risk factors that have con-
tributed to the increase in the occurrence of breast cancer 
among Saudi women.
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